Categories AlphaGraphs, Earnings, Health Care
Merck (MRK) swings to profit in Q2 on higher revenues; earnings beat
Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported net profit for the second quarter of 2024, on an adjusted basis, compared to a loss last year. Both sales and earnings exceeded the market’s expectations.
Second-quarter worldwide sales increased 7% year-over-year to $16.11 billion, mainly reflecting continued growth in the sales of vaccines and oncology/cardiovascular products. Wall Street was looking for slower growth.
The company reported a net profit of $5.46 billion or $2.14 per share for the June quarter, compared to a loss of $5.98 billion or $2.35 per share in the prior-year period. On an adjusted basis, net income was $2.28 per share, compared to a loss of $2.06 per share in the second quarter of 2023. The bottom line topped expectations.
“I am proud of our dedicated teams around the world that are working tirelessly to advance our deep pipeline as we continue delivering innovation that solves unmet medical needs,” said Merck’s CEO Robert Davis.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
GIS Earnings: All you need to know about General Mills’ Q1 2025 earnings results
General Mills, Inc. (NYSE: GIS) reported its first quarter 2025 earnings results today. Net sales decreased 1% year-over-year to $4.8 billion. Organic sales were down 1%. Net earnings attributable to
Guardian Pharmacy seeks to raise up to $108 mil in US IPO
Joining the wave of healthcare IPOs this year, amid Fed rate cut expectations, Guardian Pharmacy Services, Inc. is preparing to go public. In a statement filed with the Securities and
Earnings Preview: Will Micron (MU) maintain recovery momentum in Q4?
After recovering from a rough patch, Micron Technology Inc. (NASDAQ: MU) is preparing to report fourth-quarter results next week, even as the market keeps a close watch on the event
